Literature DB >> 21050241

There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study.

M Dall1, O B Schaffalitzky de Muckadell, A T Lassen, J Hallas.   

Abstract

BACKGROUND: Persons who use serotonin reuptake inhibitors (SSRIs) seem to be at increased risk of having serious upper gastrointestinal bleeding. In vitro studies have shown that SSRIs inhibit platelet aggregation. It remains unknown if SSRIs have a direct ulcerogenic effect. AIM: To investigate if there is a possible association between use of SSRIs and uncomplicated peptic ulcers.
METHODS: A population-based case-control study was conducted in the county of Funen, Denmark, using local prescription database and patient register. The 4862 cases all had a first diagnosis of uncomplicated peptic ulcers from 1995 to 2009. Controls (n = 19 448), matched for age and gender, were selected by risk-set sampling.
RESULTS: The adjusted odds ratios (OR) of uncomplicated peptic ulcers among current, recent and past users of SSRIs were 1.50 (95% CI 1.18-1.90), 1.56 (95% CI 0.98-2.49) and 1.32 (95% CI 1.08-1.61). There was no association with tricyclic antidepressants [OR 0.94 (95% CI 0.65-1.35)]. The adjusted OR for the SSRI-uncomplicated peptic ulcers association was 0.76 (95% CI 0.46-1.25) among users of proton pump inhibitors.
CONCLUSIONS: Use of SSRI is associated with uncomplicated peptic ulcers, possibly by some effect on the healing process. We cannot exclude some effects of residual confounding or bias by frequent physician contact.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050241     DOI: 10.1111/j.1365-2036.2010.04472.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

1.  Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?

Authors:  Koen B Pouwels; Gerard A Kalkman; Daan Schagen; Sipke T Visser; Eelko Hak
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

2.  Measuring psychotropic drug exposures in register-based studies--validity of a dosage assumption of one unit per day in older Finns.

Authors:  Maria Rikala; Sirpa Hartikainen; Leena K Saastamoinen; Maarit Jaana Korhonen
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-16       Impact factor: 4.035

Review 3.  Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.

Authors:  Francisco J de Abajo
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

4.  Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.

Authors:  Rebecca N Jerome; Meghan Morrison Joly; Nan Kennedy; Jana K Shirey-Rice; Dan M Roden; Gordon R Bernard; Kenneth J Holroyd; Joshua C Denny; Jill M Pulley
Journal:  Drug Saf       Date:  2020-06       Impact factor: 5.606

Review 5.  The role of nitric oxide in peptic ulcer: a narrative review.

Authors:  Tian-Yu Liang; Ru-Ming Deng; Xiang Li; Xiang Xu; Gang Chen
Journal:  Med Gas Res       Date:  2021 Jan-Mar

6.  Positive predictive value of peptic ulcer diagnosis codes in the Danish National Patient Registry.

Authors:  Søren Viborg; Kirstine Kobberøe Søgaard; Peter Jepsen
Journal:  Clin Epidemiol       Date:  2017-05-05       Impact factor: 4.790

7.  The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study.

Authors:  Xin Xie; Kaijie Ren; Zhangjian Zhou; Chengxue Dang; Hao Zhang
Journal:  BMC Gastroenterol       Date:  2022-02-10       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.